Bain Capital Life Sciences Investors, LLC Aptinyx Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	BUY	$2.93 - $4.3 $9.77 Million - $14.3 Million	3,333,333 Added 59.97%	8,891,758 $30.8 Million
Q1 2020 May 15, 2020	BUY	$1.81 - $5.03 $6.03 Million - $16.8 Million	3,333,333 Added 149.81%	5,558,425 $12 Million
Q2 2018 Aug 14, 2018	BUY	$19.83 - $24.17 $44.1 Million - $53.8 Million	2,225,092 New	2,225,092 $53.8 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.